Goldman Sachs Trims PT on Hologic (HOLX) After Q1, Keeps 'Buy'

February 5, 2013 7:31 AM

Goldman Sachs trimmed its price target on Hologic (NASDAQ: HOLX) from $25 to $24 following in-line Q1 results and below-consensus ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found